Comment from Consumer Healthcare Products Association

Summary: The Consumer Healthcare Products Association (CHPA) supports the FDA's efforts to update the SUPAC guidances and suggests specific improvements to enhance clarity and consistency. They advocate for a more structured, risk-based framework that aligns with international standards, incorporates modern quality system tools, and addresses current gaps such as oral liquid dosage forms.